Former Terns CEO Senthil Sundaram passes away following battle with cancer
Senthil Sundaram, a seasoned biotech executive who most recently served as CEO of Terns Pharmaceuticals, has passed away, the company said late Monday.
Sundaram had been battling cancer since early 2022, when Terns disclosed he would “undergo aggressive treatment” and limit certain business activities such as travel. But he stayed on as CEO until August of this year, when he decided to step down. He passed away on November 22, according to Terns.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.